APA (7th ed.) Citation

Gao, R., Liang, W., Chen, J., Yang, M., Yu, X., & Wang, X. Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: A real-world disproportionality analysis based on the FDA adverse event reporting system. BMC.

Chicago Style (17th ed.) Citation

Gao, Ruichen, Wenjun Liang, Jintao Chen, Mingxia Yang, Xiaowei Yu, and Xiaohua Wang. Comparisons of Adverse Events Associated with Immune Checkpoint Inhibitors in the Treatment of Non-small Cell Lung Cancer: A Real-world Disproportionality Analysis Based on the FDA Adverse Event Reporting System. BMC.

MLA (9th ed.) Citation

Gao, Ruichen, et al. Comparisons of Adverse Events Associated with Immune Checkpoint Inhibitors in the Treatment of Non-small Cell Lung Cancer: A Real-world Disproportionality Analysis Based on the FDA Adverse Event Reporting System. BMC.